Reasons to keep holding Admedus shares, page-34

Some posters have commented on the difficulty in getting surgeons to change products and habits and the various reasons for that and also the huge task that our sales people face in getting CardioCel accepted as the premier solution. The following is an extract from a report on claims against Cardiovascular Systems Inc. which probably reinforces the views of some posters that incentives are offered to surgeons to use a particular product -
"The FCA suit, filed in 2013 and unsealed 2 years later, accuses CSI of inducing physicians to use its products by offering free, all-expense-paid training programs “followed by explicit demands by CSI employees that attendees use CSI products on future patients,” giving away product for free, 3rd-party referral channel marketing, and “sham Speaker Bureau payments for high-prescribers and others whom CSI sought to cultivate,” according to the complaint filed in the U.S. District Court for Western North Carolina."
Attached is a link to the full article -
http://www.massdevice.com/sharehold...systems-wins-extension-settle-kickbacks-case/